ALASTIN A-Luminate Brightening Serum

Clinically proven to help minimize the appearance of all forms of (unwanted) discoloration, including dark spots, age spots, hyperpigmentation, and brown patches.

• Proprietary PATH-3 Technology helps to minimize the recurrence of surface pigmentation and protect against future damage with continued use.
• Improves the appearance of redness that often accompanies the look of hyperpigmentation.
• Helps skin appear brighter and more luminous over time.
• Powerful antioxidants help promote optimal skin health.
• Non-hydroquinone and non-retinol formula.
• Non-irritating for daily use.
• Elegant, lightweight serum works well under makeup.

• In the morning and evening after cleansing, apply 1-2 pumps of serum to the face.
• In the AM, apply sunscreen after applying A-LUMINATE.
• Avoid getting in the eyes. If contact occurs, rinse thoroughly with water.

Water/Aqua/Eau, Squalane, Glycerin, Niacinamide, Sodium Acrylates Copolymer, Thermus Thermophillus Ferment, Tranexamic Acid, Glucosyl Hesperidin, Silybum Marianum Fruit Extract, Withania Somnifera Root Extract, Lactoferrin, Plankton Extract, Tremella Fuciformis Sporocarp Extract, Pancratium Maritimum Extract, Dunaliella Salina Extract, Pentasodium Tetracarboxymethyl Acetylhydroxyprolyl Dipeptide-12, Hexapeptide-11, Hexapeptide-12, Pentasodium Tetracarboxymethyl Dipeptide-51, Diglucosyl Gallic Acid, Phospholipids, Fructose, Betaine, Ascorbyl Palmitate, Propanediol, Lecithin, Caprylyl Methicone, Dimethicone, Mannitol, Phosphatidylcholine, 1,2-Hexanediol, Cetyl Alcohol, Xanthan Gum, Tocopherol, Citric Acid, Helianthus Annuus (Sunflower) Seed Oil, Decyl Glucoside, Caprylyl Glycol, Ethylhexylglycerin, Caprylhydroxamic Acid, Potassium Sorbate, Sodium Benzoate, Phenoxyethanol, Sodium Chloride, Silica, Tin Oxide, CI 77891 (Titanium Dioxide).

90% of participants agreed their skin looked brighter and more radiant after 12 weeks of use^

90% of participants agreed that the overall appearance of their skin was improved after 8 weeks of use^

86% of participants agreed that the appearance of their dark spots and discoloration was diminished after 8 weeks of use^

^Clinical Study: Multi-Center, Randomized, Blinded, Clinical Study Evaluating the Efficacy and Safety of a Topical Product for Facial Dyschromia, n=43 Subject questionnaire completed at Weeks 4, 8, and 12.